home / stock / bvs / bvs news

BVS News and Press, Bioventus Inc. From 01/24/24

Stock Information
Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Website: bioventus.com
Menu
BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...
BVS - Bioventus: Bullish On Path To Profitability

2024-01-24 14:00:34 ET Summary Shares of BVS are up more than 100% over the past year amid an ongoing financial turnaround. The company is benefiting from strong demand for its portfolio of minimally invasive medical treatment including therapeutic injections for osteoarthritis. ...
BVS - Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on January 11, 2024 of previously disclosed inducement equity awards to Robe...

BVS - EXTR, URBN and APPI are among after hour movers

2024-01-09 16:20:04 ET Gainers: WISeKey International  ( WKEY ) +14% . MaxCyte ( MXCT ) +8% . Humacyte. ( HUMA ) +8% . Agora ( API ) +6% . Urban Outfitters ( URBN ) +6% . Losers: Grifols ( GRFS ) -9% . Ex...

BVS - Bioventus appoints Robert Claypoole as president and CEO

2023-12-19 16:40:11 ET More on Bioventus Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript Bioventus Inc. 2023 Q3 - Results - Earnings Call Presentation Bioventus Stock: Improving Outlook Keeps It Interesting Seeking Alpha’s Quant Rating on Biovent...
BVS - Bioventus Names Robert Claypoole as President and Chief Executive Officer

DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’...

BVS - Bioventus Agrees to Nationwide Contract with Aetna(TM) Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1,...

BVS - Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript

2023-11-12 00:55:22 ET Bioventus Inc. (BVS) Q3 2023 Earnings Conference Call November 7, 2023 08:30 ET Company Participants Dave Crawford - Vice President, Investor Relations Tony Bihl - Chief Executive Officer Mark Singleton - Senior Vice President and Chief Fin...
BVS - Bioventus Non-GAAP EPS of $0.05 beats by $0.07, revenue of $120.8M beats by $1.8M

2023-11-07 07:42:50 ET More on Bioventus Bioventus Stock: Improving Outlook Keeps It Interesting Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Bioventus Historical earnings data for Bioventus Financial in...

BVS - Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

DURHAM, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 30, 2023. Q3 Financial Summary: N...

BVS - Expected US Company Earnings on Tuesday, November 7th, 2023

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Previous 10 Next 10